Kaposi's Sarcoma in A Subject Treated for Dermatomyositis With Immunosuppressant and Steroid

  • Bandana Bhardwaj
  • Shivani Thakur
Keywords: Dermatomyositis, Kaposi's Sarcoma, Cyclosporine

Abstract

The incidence of Kaposi's sarcoma has increased in recent years mainly because its association with the acquired immunodeficiency syndrome and organ transplant recipients treated with immunosuppressive drugs, especially with cyclosporine. We present the case of a patient with dermatomyositis who developed Kaposi's sarcoma after receiving treatment with steroids, cyclosporine, and human polyclonal immunoglobulin.

Downloads

Download data is not yet available.

Author Biographies

Bandana Bhardwaj

MD (Internal Medicine), Consultant Private Practitioner, Bhuntar, District Kullu, India.

Shivani Thakur

MBBS Intern, Bhuntar, District Kullu, India.

References

Tappero JW, Conant MA, Wolfe SF, Berger TG. Kaposi's sarcoma. J Am Acad Dermatol. 1993;28:371-95.

Morris PJ. Cyclosporin A (overview). Transplantation 1981; 32:349-54

Penn I, First MR. Development and incidence of cancer following cyclosporine therapy. Transplant Proc. 1986; 43 (Supl 1):210-13.

Penn I. Cancers after cyclosporine therapy. Transplant Proc 1988; 120 (Supl 1):276-9.

Zabel P, Leimenstoll A, Gross WL. Cyclosporin for acute dermatomyositis (letter). Lancet 1984; I: 343.

Dankó K, Szegedi G. Cyclosporin A treatment of dermatomyositis (letter). Arthritis Rheum 1991; 34:933-4.

Sigurgeirsson B, Lindelöf B, Edhag O, Allander E. Risk of cancer in patient with dermatomyositis or polymyositis. N Engl J Med 1992;326:363-7.

Richardson JB, Callen JP. Dermatomyositis and malignancy. Med Clin North Ann 1989; 73: 1.211-1.220.

Dantzig PI. Kaposi sarcoma and polymyositis. Arch Dermatol 1974; 110:605-7.

Weiss VC, Serushan M. Kaposi's sarcoma in a patient with dermatomyositis receiving immunosuppressive therapy. Arch Dermatol 1982; 118:183-5.

Almog Y, Ben-Yehuda A, Ben-Chetrit E. Dermatomyositis associated with the recurrence of transitional cell carcinoma and Kaposi's sarcoma. Clin Exp Rheumatol 1991; 9: 285-8.

Carmeli Y, Mevorach D, Kaminski N, Raz E. Regression of Kaposi's sarcoma after intravenous immunoglobulin treatment for polymyositis. Cancer 1994; 73: 2.859-2.861.

Becini PL, Montgnino G, Tarantino A, Alessi E, Ponticelli C, Caputo R. Kaposi's sarcoma in kidney transplant recipients. Arch Denmatol. 1993; 129: 248-50.

Trattner A, Hodak E, David M, Sandback M. The appearance of Kaposi 's sarcoma during corticosteroid therapy. Cancer 1993; 72: 1.779-1.783.

Cherin P, Herson S, Wechesler B, Piette JL, Bletry O, Coutellies A, Ziza JM, Godeau P. Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermatomyositis. An Open Study in 20 Adult Patients. Am J Med. 1991; 91: 162-7.

Moore PS, Chang Y. Detection of herpesvirus-like DNA Sequences in Kaposi's sarcoma lesions from persons with and without HIV infection. N Engl J Med. 1995; 332: 1.181-1.185.

CITATION
DOI: 10.26440/IHRJ/0512.03513
Published: 2022-03-28
How to Cite
1.
Bandana Bhardwaj, Shivani Thakur. Kaposi’s Sarcoma in A Subject Treated for Dermatomyositis With Immunosuppressant and Steroid. IHRJ [Internet]. 2022Mar.28 [cited 2023Feb.2];5(12):CR1-CR3. Available from: https://ihrjournal.com/ihrj/article/view/513